Kang, J. H., Ahn, M., Kim, D., Cho, E. K., Kim, J., Shin, S. W., . . . Park, K. (2016). Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial. Cancer Research & Treatment, 48(2), 458-464. https://doi.org/10.4143/crt.2015.135

Kang, Jin Hyoung, et al. "Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial." Cancer Research & Treatment 48, no. 2 (2016): 458-464. https://doi.org/10.4143/crt.2015.135.

Kang, Jin Hyoung, et al. "Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial." Cancer Research & Treatment, vol. 48, no. 2, 2016, pp. 458-464, https://doi.org/10.4143/crt.2015.135.